New study explores urinary management in people with spinal cord injury
Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.
Newsroom
News and milestones
From the first European grants in 2017 to the CE mark in 2025 — the milestones that have shaped Rethink Medical and T-Control®.
2026
Rethink Medical presents T-Control® at the 48th Spanish Neuroscience Nursing Congress
Rethink Medical participated in the 48th Congress of the Spanish Neuroscience Nursing Association, sharing the journey from identifying an unmet need in clinical practice to developing a regulated medical device.
Rethink Medical reaches the minimum target of its 2026 investment round
Rethink Medical reached the minimum target of its 2026 investment round ahead of the initially planned closing date.
Rethink Medical participates in WHX Dubai 2026
Rethink Medical participated in WHX Dubai 2026, one of the major international meeting points for the healthcare and medical-technology sector.
Manuel Luque appointed CEO of Rethink Medical
Rethink Medical entered 2026 with a renewed leadership structure, with co-founder Manuel Luque assuming the role of CEO from 1 January 2026.
2025
Rethink attends MEDICA Düsseldorf with a Canarian business and government delegation
Rethink Medical participated in MEDICA Düsseldorf as part of a joint expedition of Canarian health-tech companies, alongside an official delegation from the Government of the Canary Islands.
View news
T-Control® Highlighted by Fenin
Thank you to Fenin for recognizing our solution, T-Control®, as part of their ongoing commitment to driving innovation in healthcare.
Sharing the T-Control® Journey at the ENFURO Annual Congress
At Rethink Medical, we’re proud and grateful for the opportunity to share the story behind T-Control® during the annual congress of ENFURO.
T-Control® Achieves CE Mark Certification
Our T-Control® urinary catheter has officially received the CE Mark, certifying its compliance with European safety and performance standards.
Abstract Accepted at the XLIV AES Health Economics Conference
Our abstract has been approved for presentation at the XLIV Health Economics Conference, organised by the Spanish Health Economics Association (AES).
View publication2024
New Study Published in IJUN
We are proud to announce the publication of one of our latest studies in the International Journal of Urological Nursing (IJUN).
View article
Published our new study “Practices related to bladder catheterization: A survey of Spanish healthcare professionals”
Our study on practices related to urinary catheterization among Spanish healthcare professionals is published in Enfuro magazine.
View article
Dr. José Medina Polo Presents Advances of T-Control® at the International Continence Society Congress
Dr. Jose Medina Polo presented the accepted poster at the International Continence Society (ICS), where we shared the preliminary results of T-Control®.
La Razón Highlights Our T-Control® Project and Funding Round
The newspaper La Razón has published a detailed article about our innovative T-Control® project and our recent funding round.
View news
El Español publishes an article on Rethink Medical
The newspaper El Español has published an article highlighting our company and the market launch of our urinary catheter in 2025.
View news
Published our new study on urinary catheterization performed by nursing students
A direct comparison between the common Foley catheter and T-Control® gives us an insight about the difficulties of the insertion technique.
View article
Published our new study “Comparative study of in vitro Biofilm formation”
Comparative in-vitro findings on biofilm formation with T-Control®. In-vitro results do not establish reduced clinical infection risk.
View article
Rethink Medical among the 6 chosen for the Emprende inHealth program by Lilly and Unlimited
The inHealth program by Lilly and Unlimited begins its 9th edition, supporting six projects including Rethink Medical with the T-Control® urinary catheter.
View on LinkedIn
Our abstract has been accepted for ICS 2024, which will be held in Madrid
The first clinical study results with our T-Control® urinary catheter will be presented in public at the International Continence Society Congress 2024.
View publication
European Association of Urology Nurses Paris 2024
See you at EAUN24 where our work around urinary catheterization will be presented, with interesting results from our survey in Sweden.
View event
Rethink Medical on the way to the SESSEP National Congress
We are delighted to present the results of our Living Lab with the T-Control® urinary catheter at the SESSEP National Congress.
View event
Szilvia Endrényi: “Contributing to a better world in healthcare sector is what motivates us the most”
After being recognised as one of Spain's top 100 startups by the APTE, our CEO was interviewed by InnovaSpain.
View news
Rethink Medical represented at the III Biomedical and Health Research Conference of the Canary Islands
Clara Armas, junior researcher at Rethink Medical, stood out at the III Biomedical and Health Research Conference of the Canary Islands 2024.
Rethink Medical Recognised as One of the Top 100 Startups of 2023 by the Association of Science and Technology Parks of Spain (APTE)
APTE has unveiled its annual list of the top 100 startups of 2023, and Rethink Medical is proud to be acknowledged among them.
View official source
Rethink Medical in FORBES!
We have been selected among the 24 Changemakers for 2024 by FORBES magazine in Spain.
View news2023
Rethink Medical Clinches Top Prize at “Canarias Destination Startup”
Our company stood out among the best startups in the final of “Canarias Destination Startup”, securing the first prize of the event.
Rethink Medical at the Healthcare Investment Forum in Barcelona
Szilvia Endrényi, co-founder and CEO of Rethink Medical, introduces T-Control® at the Healthcare Investment Forum of the Barcelona Medical College.
LSI Presentation: Our CEO Szilvia Endrényi on the Global State
Our CEO had the opportunity to showcase our company at the LSI event, a pivotal platform within the medical devices sector.
View official source
New article published
The article discusses current urinary-catheterisation practice and opportunities for innovation in nursing workflows.
View article
Rethink Medical awarded €1.56M CDTI funding following EIC Seal of Excellence
Rethink Medical has been awarded a €1.56 million grant from the Center for Industrial Technological Development (CDTI).
Preparing to start a clinical study
In May we visited the University Hospital of 12 de Octubre (Madrid), where we will soon begin one of our studies with the T-Control® urinary catheter.
New collaborations to shed more light on nursing
We started a new study in Belgium with Artevelde Academy to evaluate the usability of T-Control® with midwives.
Quality management milestone
A key milestone at the beginning of the year has been the consolidation of our quality management system.
Presentation at the European Congress of Urology
Once again, we have been present at the European Urology Nursing Congress and at the European Urology Congress.
View event2022
Members at a discussion panel at the Patent Week
We participated at the round table organized by the ULPGC during the Patent Week initiative.
New incorporation
Our company has been one of the only three companies in the Canary Islands to get a research grant through the INVESTIGO program.
Rethink Medical obtain funding from SODECAN
The signing of the funding granted by SODECAN took place for the amount of €849,443.00.
Members at a panel discussion about innovation
We were invited to a panel discussion on the occasion of the conference “Emerging technology companies as an engine of innovation”.
European Urology Congress
Our CIO had the honor of being able to exhibit our Living Lab with T-Control® at the European Congress of Urology.
EMPRENDEDORES Magazine
Emprendedores magazine has dedicated an article to our CEO Szilvia Endrényi about our company and first project, T-Control®.
View news
Spanish Urology Congress
Proud to present our project at the AEU Congress hand in hand with Continentia Foundation.
EATIC 2022
An honor to have been one of the beneficiary companies in the EATIC 2022 call.
Presenters at the EAU
Improvements in indwelling bladder catheterization. Honoured to present our study at the “Affordable techniques in urology” session at the EAU22 Congress.
View event2021
Semifinalist in Innostar awards
One more recognition for this project that makes us among the semi-finalists of Innostars Awards 2021.
View official source
Winner of pitching event
We have won the pitching event held among the 15 projects that have participated in the Mentorday acceleration program.
CSC Forum “Sanitary products and other medical devices in the context of the COVID-19 pandemic”
Participation in the CSC Forum on sanitary products and other medical devices in the context of the COVID-19 pandemic.
2020
EIT Health support for pre-clinical validation
Many thanks for the EIT Health grant approved for our Living Lab activities with nurses!
Comparative in-vitro biofilm study completed
A comparative in-vitro biofilm study with T-Control® has been completed.
Patient Journey Mapping workshop
We organized a specific workshop with patients from different clinical backgrounds in order to openly talk about their experience.
2019
Winner of the Entrepreneur Awards — Mapfre Guanarteme and FULP
We have been selected as one of the winners of the Entrepreneur Awards organized by Fundación MAPFRE Guanarteme and FULP.
View news2018
Great reception of T-Control® at Healthio
T-Control® received extremely positive feedback at HealthIO Global 2018, one of the most important events in Europe in the medical innovation field.
Second round! MassChallenge
We have been selected for the 2nd round of the very demanding selection process of MassChallenge, Boston.
Acceleration! CIMTI 2018
T-Control® has been selected to be part of the accelerator program of CIMTI (Center for the Integration of Medicine and Innovative Technologies in Catalonia).
2017
SME Instrument granted — Horizon 2020
We have been granted an SME Phase I Instrument grant, as part of European initiatives supporting innovation.
2016
EIT Health Headstart 2016
Rethink Medical was selected as one of the 5 best projects submitted to the EIT Health Headstart competition in Spain.
In the media
Media Coverage
Selected independent media coverage of Rethink Medical and T-Control® across press, television, radio and digital media.
Canarian health-technology sector coverage including Rethink Medical
Regional coverage of the growth of the Canarian health-technology industry, with Rethink Medical among the companies referenced.
View article
National television coverage of Rethink Medical and T-Control®
RTVE's technology programme Zoom Net covered health innovation developed in Gran Canaria, including a segment on Rethink Medical and the T-Control® urinary catheter.
T-Control® segment approximately 13:17–14:45.
Watch on RTVE
Profile of Rethink Medical and the development of T-Control®
A profile of the Canarian company covering its origins, the development path of T-Control® and its regulatory and investment milestones at the time of publication.
View article
National coverage of Rethink Medical and innovation in urinary catheterisation
Independent national coverage of the company, its founders and the development of the T-Control® urinary catheter within the Spanish medtech ecosystem.
View article
Dedicated regional coverage of the company's market and investment roadmap
Dedicated article on Rethink Medical covering the investment round open at the time and the company's plans for bringing T-Control® to market.
View article
Rethink Medical among Forbes Spain's 24 Changemakers 2024
Forbes Spain included the founders of Rethink Medical in its annual selection of 24 Changemakers, highlighting the company's work in medical-device innovation.
View articleInnovaSpain
Rethink Medical in the APTE Top 100 startups selection
Digital media coverage of Rethink Medical being selected among the APTE Top 100 startups of Spanish science and technology parks.
View article
Rethink Medical wins the first edition of Canarias Destino Startup
Coverage within the Spanish startup and investment ecosystem of Rethink Medical winning the first edition of the Canarias Destino Startup pitch competition.
View article
Long-form profile of the company and its founding team
An extended profile covering the origins of Rethink Medical, the founding team and the development of T-Control® from clinical observation to a regulated medical device.
View articleArticles and media content listed on this page were independently produced by third-party media organisations. Headlines and statements reflect the wording and editorial views of the respective publishers and should not be interpreted as claims made by Rethink Medical regarding the intended purpose, safety or clinical performance of T-Control®. For official product information, please refer to the current Instructions for Use.